New Delhi amongst top cities where hearing is most degraded

March 5, 2017

Washington D.C, Mar 5: Urban noise pollution and hearing loss are closely linked, according to rankings of 50 large cities in both categories released on Friday.cars

High-decibel urban areas-such as Guangzhou, New Delhi, Cairo and Istanbul-topped the list of cities where hearing was most degraded, researchers reported.

Likewise, cities least afflicted by noise pollution-including Zurich, Vienna, Oslo and Munich-registered the lowest levels of decline in hearing.

This statistical link does not necessarily mean the constant din of city life is the main driver of hearing loss, which can also be caused by infections, genetic disorders, premature birth, and even some medicines.

The findings are also preliminary, and have yet to be submitted for peer-reviewed publication.

"But this is a robust result," said Henrik Matthies, managing director of Mimi Hearing Technologies, a German company that has amassed data on 200,000 people drawn from a hearing test administered via cell phones.

"The fact that noise pollution and hearing loss have such a tight correlation points to an intricate relationship," he told AFP.

Researchers at Mimi and Charite University Hospital in Berlin explored the link by constructing two separate databases.

The first combined information from the World Health Organization (WHO) and Norwegian-based technology research group SINTEF to create a noise pollution ranking for cities around the world.

Stockholm, Seoul, Amsterdam and Stuttgart were also among the least likely to assault one's ears, while Shanghai, Hong Kong and Barcelona came out as big noise makers.

Paris-one of the most densely populated major cities in Europe-scored as the third most cacophonous.

The ranking for hearing loss drew from Mimi's phone-based test, in which respondents indicated age and sex. Geo-location technology pinpointed the cities.

The results were measured against a standard for age-adjusted hearing.

On average, people in the loudest cities were ten years "older"-in terms of hearing loss-than those in the quietest cities, the study found.

Stacked side-by-side, the two city rankings are remarkably similar, suggesting more than an incidental link.

The findings highlight the need for better monitoring, the researchers said.

"While eye and sight checks are routine, ear and hearing exams are not," said Manfred Gross, head of the department of Audiology and Phoniatrics at Charite University Hospital.

"The earlier hearing loss is detected, the better the chances are for preventing further damage."

Collaborations between scientists and private companies that collect health-related information from consumers are becoming more common in the era of Big Data.

California-based DNA genetic testing company 23andMe, for example, has worked extensively with university researchers to ferret out rare genetic disorders by combing through mountains of anonymous data from its clients.

Also on Friday, World Hearing Day, the WHO released figures showing annual costs of unaddressed hearing loss of between $750 billion and $790 billion globally.

Direct health care costs were calculated to be up to $107 billion, with loss of productivity due to unemployment or early retirement about the same.

"Societal costs"-stemming from social isolation, inability to communicate and stigma-were estimated at more than $500 billion.

In a recent editorial, the medical journal The Lancet said hearing loss is a "silent epidemic", noting that proper care remains out of reach for millions of people.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 17,2020

Leading physicians are celebrating a small dose of good news that arrived Tuesday about dexamethasone, a cheap and widely used steroid shown to be able to save lives among COVID-19 patients, but also cautioning against releasing study results by press release during a global health emergency, like in the case of the latest dexamethasone study by University of Oxford.

"It will be great news if dexamethasone, a cheap steroid, really does cut deaths by one-third in ventilated patients with COVID19, but after all the retractions and walk backs, it is unacceptable to tout study results by press release without releasing the paper", Atul Gawande, surgeon and CEO of Haven Healthcare, tweeted.

"Bottom line is, good news," Dr. Fauci, America's foremost infectious diseases expert told a US newswire on Tuesday, soon after the dexamethasone results were announced in the UK.

Fauci, who has long championed the therapeutics-first view said that dexamethasone is a "significant improvement" in the available therapeutic options currently available.

On Medical Twitter and Facebook, doctors broadly agree that dexamethasone use aligns well with the way COVID19 attacks the body's immune system. Fauci said the results in the Oxford study make "perfect sense" in that context.

"We should see the number of people who actually survive go up, if the study holds up," virologist and epidemiologist Dr. Joseph Fair told a television network.

Global coronavirus cases crossed 8 million on Tuesday. In the US, Texas and Florida are facing a new wave of cases after lifting lockdown orders earlier than medical experts recommended. Amidst the relentless graph upwards, the dexamethasone study results injected hope for better survival rates among those most seriously ill.

World Health Organization chief scientist Soumya Swaminathan welcomed the results from the randomised control trial.

Dr Eugene Gu, Founder and CEO of CoolQuit tweeted that he is "genuinely impressed" with the UK dexamethasone trial. This may be a "game changer", he wrote.

"There's no conflict of interest as dexamethasone is a generic steroid. The mechanism of action makes sense because steroids can reduce cytokine storms and overactive immune systems that makes COVID-19 so deadly. The number needed to treat is 8 ventilated patients which is great."

The Oxford study found that dexamethasone reduced deaths by 35 percent in patients who needed treatment with breathing machines and by 20 percent in those only needing supplemental oxygen. Dexamethasone was one of 5 drugs studied in a large clinical trial in the United Kingdom named RECOVERY, short for Randomised Evaluation of COVID-19 Therapy.

Peter Horby, chief investigator of the University of Oxford clinical trial, said dexamethasone is the first drug to be shown to improve survival in COVID-19. Details of the study have not been released. The trial organisers said they made their announcement via a news release because of "the public health importance of these results." According to Horby's public comments, there was a lot of initial resistance to studying steroids.

During the study, 2,104 patients were randomly selected to be given 6 milligrams of dexamethasone once a day (either by mouth or by intravenous injection) for 10 days. That group was compared with 4,321 patients who received the usual care alone.

Researchers estimated that dexamethasone would prevent one death for every eight patients treated while on ventilators and one for every 25 patients on extra oxygen alone.

UK experts have called the study results a breakthrough in the fight against the virus. The researchers have promised they would publish the results soon.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 5,2020

Washington D.C., Jan 5: After a woman filed a lawsuit against a diet soda company, the California court has declared that the beverage does not promise to help buyers in losing weight.

The woman had gulped down the drink for over a decade but did not lose inches as a result.

The three-judge panel declared during the hearing: "The prevalent understanding of the term in (the marketplace) is that the 'diet' version of a soft drink has fewer calories than its 'regular' counterpart."

However, the members of the US 9th circuit court have felt that the consumers tend to make out something of their own that is unreasonable and eventually hamper the reputation of brands through a deceptive allegation, reports Fox News.

The response was due to a misleading case filed against Diet Dr Pepper by Shana Becerra from Santa Rosa, California. Shana claimed that she has been addictively purchasing the low-calorie beverage for the past 13 years hoping for losing some fat but failed to lose even a single inch.

The woman also stated that the attractive and fit models misled her into believing that drink will help her in perfecting her body like them.

However, the court's decision was that advertisements are for representational purposes only. "Cannot be reasonably understood to convey any specific meaning at all," as written by Judge Jay Bybee.

Shana had last week made such allegation against Diet coke as well where the court came to a similar verdict. She claimed that she had found various studies where it is evident that the artificial sweetener aspartame used in diet beverages actually boosts weight gain.

But the artificial sweetener is approved in by the concerned administrative department and thus is used in most American drinks.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.